10.08.2021 13:00:00

Benson Hill Announces Second Quarter 2021 Financial Results

ST. LOUIS, Aug. 10, 2021 /PRNewswire/ -- Benson Hill, Inc. (the "Company" or "Benson Hill"), a food tech company unlocking the natural genetic diversity of plants with its cutting-edge food innovation engine, today announced operating and financial results for the quarter ended June 30, 2021.

“We are pleased with the performance we achieved in the second quarter and first half of 2021,” said Matt Crisp, Chief Executive Officer of Benson Hill.

"We are pleased with the performance we achieved in the second quarter and first half of 2021," said Matt Crisp, Chief Executive Officer of Benson Hill. "Our teams did a terrific job delivering on the financial and operating objectives we set, with strong revenue growth in the second quarter in both our Ingredients and Fresh business segments. We continue to make significant headway towards scaling the production and commercialization of our innovative soybean feed, ingredient, and specialty cooking oil products. We are excited about the impending harvest of the first commercial plantings of our Ultra-High Protein soybeans, which will expand our soy portfolio to offer our customers and consumers a non-GMO, traceable and more sustainably made protein ingredient for the fast-growing plant-based food market."

"Our top priority is to build mutual trust with our partners and customers, and to deliver innovative products that address significant and rapidly growing market demands," Crisp continued. "By creating a better seed, we can enable the advancement of the food system by aligning interests of consumers and growers, while providing more sustainably made products. To that end, we have strategic initiatives underway to accelerate future crop development, enable our integrated business model for soy and further advance our innovation efforts in yellow pea protein ingredients. We announced the launch of our advanced yellow pea breeding and commercialization program today and our Crop Accelerator is on track to be operational by the end of 2021. These important initiatives and a continuous focus on execution are creating the foundation for our future growth as we become the 'picks and shovels' of the plant-based revolution."

Second Quarter 2021 Results

Reconciliation of non-GAAP financial measures can be found on page 14.

  • Revenues were $39.7 million, an increase of $8.7 million, or 28%, compared to the second quarter of 2020. Revenues increased 47% on a normalized basis, excluding $4.0 million in the prior year period from a non-core barley business divested in late 2020.
  • Gross profit was a loss of $0.1 million in the quarter due to non-recurring costs of $2.8 million. The Company utilized higher cost air transportation from South America to accelerate the delivery of its proprietary seeds, including Ultra-High Protein soybean varieties, for planting in this crop year. Excluding this non-recurring cost, adjusted gross profit was $2.8 million in the quarter or 7.0% of sales.
  • Reported net loss was $27.4 million compared to a loss of $12.7 million in the prior year period.
  • Adjusted EBITDA was a loss of $15.8 million compared to $8.4 million loss in the prior year period. The results in the quarter were largely in line with expectations.

Ingredients Segment Second Quarter Results

Revenues for the segment were $22.7 million, an increase of $4.9 million, or 28%, as compared to the prior year period. Excluding $4.0 million of sales in Q2 2020 from the divested barley operations, Ingredient Segment revenues increased 64%. The performance in the quarter was attributable to the commercialization of the Company's Veri™ cooking oil derived from Benson Hill's proprietary soybean seed with the benefit of omega-9 fatty acids, as well as high protein and lower anti-nutrient soybean meal for the animal feed market and higher average selling prices for conventional yellow pea ingredients.

Adjusted EBITDA for the segment was a loss of $6.4 million, which represents a decrease of $3.9 million as compared to the same period in 2020. The Company incurred $2.8 million of non-recurring seed production costs, including freight, to accelerate the plantings of its Ultra-High Protein soybean seed. In addition, higher average selling prices were more than offset by startup and other operating costs associated with early-stage commercialization of proprietary soybean products. Adjusted EBITDA was also impacted by higher research and development costs, compared to the prior year, associated with products anticipated to be commercialized within this segment. In Q2 2020, the barley operations, divested in October of 2020, contributed $0.6 million in gross profit.

Fresh Segment Second Quarter Results

Revenues for the segment were $16.9 million, an increase of $4.7 million, or 39%, compared to $12.2 million in the prior year period. The revenue increase was primarily driven by higher sales volumes of conventional fresh produce, which was partially offset by lower average selling prices. Higher regional and ex-U.S. farm yields led to more supply versus demand, and as a result, lower average selling prices across the industry.

Segment adjusted EBITDA was a profit of $0.2 million, a decline of $0.7 million as compared to the same period in 2020. This decrease was primarily driven by lower average selling prices and higher freight costs, which partially offset higher sales volumes.

Development Update

Benson Hill exceeded its previous target of doubling contracted acres of its proprietary soybean varieties. The Company contracted with partner farmers in the U.S. to grow approximately 70,000 acres in the 2021 crop year versus 30,000 acres in the 2020 crop year, representing an approximately 133% year-over-year growth. These proprietary non-GMO soybean varieties are bred by Benson Hill to be higher in protein, have benefits of omega-9 fatty acids and low anti-nutrients. This year's crop plans include the first commercial plantings of Benson Hill's Ultra-High Protein soybeans, which enables serving the human food ingredients market. Additional proprietary products from this crop year include feed ingredients for aquaculture and swine as well as the specialty cooking oil markets. 

Innovation and Technology Initiatives

Yellow Pea Breeding Station and Commercialization Program: Three years ago, Benson Hill began investing in innovation and critical infrastructure to develop improved yellow pea ingredients. Yellow pea has traditionally received little genomic innovation. Today, yellow pea is the fastest-growing source of protein for the rapidly expanding plant-based protein market as well as the pet food and animal feed markets. The Company in 2019 created a comprehensive mapping of the yellow pea genome for its proprietary CropOS® innovation platform, which uses artificial intelligence and machine learning to identify promising seed candidates. As an outgrowth of its significant progress in yellow pea genomics since the program's inception, Benson Hill recently launched an advanced yellow pea breeding station and commercialization program to shorten the typical development cycle of new seed varieties. The yellow pea breeding station located in Minot, N.D., is in close proximity to the Company's wholly owned yellow pea operating subsidiary Dakota Ingredients. Benson Hill is working to develop varieties with less off-flavors, potentially limiting the need for additives in plant-based food product formulations, and high protein content to reduce the need for expensive, environmentally intensive processing steps typically required to produce current commodity yellow pea protein ingredients.

Crop Accelerator: Benson Hill'sCrop Accelerator is on-track to be operational by the end of 2021. The 47,000 square-foot facility will feature 20,000 square feet of dynamically adaptive Conviron growth houses and chambers, equipped with multi-channel LEDs, additive CO2, temperature, humidity and lighting controls. The innovative facility is expected to enable plant breeding to develop varieties significantly faster than traditional breeding methods. The Crop Accelerator is expected to enhance Benson Hill's capabilities to leverage the data science, plant science and food science through its CropOS® technology platform. These unique technologies can accelerate and scale the delivery of novel plant-based food and ingredient options to meet rising global demand.

Consolidated Six Month 2021 Highlights

Reconciliation of non-GAAP financial measures can be found on page 14.

  • Revenues were $71.5 million, an increase of $8.9 million, or 14% as compared to the first six months of 2020. Revenues increased 32% excluding $8.5 million in 2020 revenues from the divested barley business. 
  • Gross profit was $0.5 million. Excluding $2.8 million in excess freight costs incurred during the second quarter, gross profit was $3.3 million, 4.7% of sales.
  • Reported net loss was $49.8 million compared to a loss of $24.8 million in the first half of 2020.
  • Adjusted EBITDA was a loss of $30.6 million compared to a $17.7 million loss in the prior year period.
  • Cash and marketable securities were $42.6 million as of June 30, 2021.

For more information, please see Star Peak Corp II current amended S-4 registration statement, as filed with the SEC (here).

Benson Hill and Star Peak II Business Combination

On May 8, 2021, Benson Hill, Star Peak Corp II ("STPC" or "Star Peak") and STPC II Merger Sub Corp., a wholly owned subsidiary of STPC ("Merger Sub"), entered into a merger agreement pursuant to which Benson Hill will be merged with and into Merger Sub, with Benson Hill surviving the merger as a wholly owned subsidiary of STPC. The transaction is expected to provide the combined entity New Benson Hill with approximately $625 million of gross proceeds, assuming no redemptions, including a $225 million fully committed PIPE at $10.00 per share. Upon closing, Benson Hill will be deemed the accounting predecessor and the combined entity will be the successor registrant with the SEC, meaning that Benson Hill's consolidated financial statements for previous periods will be disclosed in the New Benson Hill's (formerly STPC's) future periodic reports filed with the SEC. 

Following the expected Q3 2021 transaction close, the combined company will have an estimated enterprise value of $1.35 billion and will be listed on the New York Stock Exchange under the new ticker symbol BHIL.

Webcast

A webcast of the conference call is available here.

About Benson Hill

Benson Hill moves food forward with the CropOS® platform, a cutting-edge food innovation engine that combines data science and machine learning with biology and genetics. Benson Hill empowers innovators to unlock nature's genetic diversity from plant to plate, with the purpose of creating healthier, great-tasting food and ingredient options that are both widely accessible and sustainable. More information can be found at bensonhill.com or on Twitter at @bensonhillinc.

On May 10, 2021, Benson Hill announced a definitive business combination agreement with Star Peak Corp II (NYSE: STPC). Upon the closing of the business combination, Benson Hill will become publicly traded on the New York Stock Exchange under the new ticker symbol "BHIL". Additional information about the transaction can be viewed at: https://bensonhill.com/investors/ or https://stpc.starpeakcorp.com/.

Additional Information

This communication is being made in respect of a proposed merger (the "Merger") and related transactions (the "proposed transactions") involving Star Peak and Benson Hill. The proposed transactions will be submitted to stockholders of Star Peak for their consideration and approval at a special meeting of stockholders. In addition, Benson Hill will solicit written consents from its stockholders for approval of the proposed transactions. In connection with the proposed transactions, Star Peak has filed a Registration Statement on Form S-4 (the "Registration Statement") with the Securities and Exchange Commission (the "SEC"), which includes a proxy statement to be distributed to Star Peak stockholders in connection with Star Peak's solicitation for proxies for the vote by Star Peak's stockholders in connection with the proposed transactions and other matters as described in such Registration Statements and a prospectus relating to the offer of the securities to be issued to Benson Hill's stockholders in connection with the completion of the Merger. After the Registration Statement has been declared effective, Star Peak will mail a definitive proxy statement / prospectus and other relevant documents to its stockholders as of the record date established for voting on the proposed transactions. Investors, Star Peak's stockholders and other interested parties are advised to read the preliminary proxy statement, and any amendments thereto, and, when available, the definitive proxy statement in connection with Star Peak's solicitation of proxies for its special meeting of stockholders to be held to approve the proposed transaction because the proxy statement / prospectus will contain important information about the proposed transaction and the parties to the proposed transaction. Stockholders will also be able to obtain copies of the proxy statement / prospectus, without charge, once available, at the SEC's website at www.sec.gov or by directing a request to: Star Peak Corp II, 1603 Orrington Avenue, 13th Floor, Evanston, Illinois 60201.

No Offer or Solicitation

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Participants in the Solicitation

Star Peak and Benson Hill and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of Star Peak's stockholders in connection with the proposed transaction. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies in connection with the proposed transaction, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in the Registration Statement that has been filed with the SEC by Star Peak, which includes the proxy statement / prospectus for the proposed transaction. Information regarding the directors and executive officers of Star Peak is contained in Star Peak's filings with the SEC, and such information is also in the Registration Statement that has been filed with the SEC by Star Peak, which includes the proxy statement / prospectus for the proposed transaction.

Use of Non-GAAP Financial Measures

In this press release, the Company includes Adjusted EBITDA, which is a non-GAAP performance measure that the Company uses to supplement its results presented in accordance with U.S. GAAP. As required by the rules of the SEC, the Company has provided herein a reconciliation of the non-GAAP financial measure contained in this press release to the most directly comparable measure under GAAP. The Company's management believes Adjusted EBITDA is useful in evaluating its operating performance and is a similar measure reported by publicly-listed U.S. competitors, and regularly used by securities analysts, institutional investors, and other interested parties in analyzing operating performance and prospects. By providing this non-GAAP measure, the Company's management intends to provide investors with a meaningful, consistent comparison of the Company's profitability for the periods presented. Adjusted EBITDA is not intended to be a substitute for any U.S. GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry.

The Company defines and calculates Adjusted EBITDA as earnings from continuing operations before net interest expense, income tax provision and depreciation and amortization, further adjusted to exclude stock-based compensation, and the impact of significant non-recurring items.

Forward-Looking Statements

Certain statements in this communication may be considered "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or Star Peak's or Benson Hill's future financial or operating performance. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "expect," "intend," "will," "estimate," "anticipate," "believe," "predict," or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Star Peak and its management, and Benson Hill and its management, as the case may be, are inherently uncertain factors that may cause actual results to differ materially from current expectations include, but are not limited to: 1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive merger agreement with respect to the business combination; 2) the outcome of any legal proceedings that may be instituted against Star Peak, the combined company or others following the announcement of the business combination and any definitive agreements with respect thereto; 3) the inability to complete the business combination due to the failure to obtain approval of the stockholders of Star Peak, to obtain financing to complete the business combination or to satisfy other conditions to closing; 4) changes to the proposed structure of the business combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the business combination; 5) the ability to meet the New York Stock Exchange's listing standards following the consummation of the business combination; 6) the risk that the business combination disrupts current plans and operations of Benson Hill as a result of the announcement and consummation of the business combination; 7) the ability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; 8) costs related to the business combination; 9) changes in applicable laws or regulations; 10) the possibility that Benson Hill or the combined company may be adversely affected by other economic, business and/or competitive factors; 11) Benson Hill's estimates of its financial performance; 12) the impact of the COVID-19 pandemic and its effect on business and financial conditions; and 13) other risks and uncertainties set forth in the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in Star Peak's Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 31, 2021, in the Registration Statement containing the proxy statement / prospectus relating to the proposed business combination, and other documents filed or to be filed with the SEC by Star Peak. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward looking statements will be achieved. There may be additional risks that Star Peak and Benson Hill presently do not know or that Star Peak and Benson Hill currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Neither Star Peak nor Benson Hill undertakes any duty to update these forward-looking statements, except as otherwise required by law.



Condensed Consolidated Balance Sheets

(In Thousands)



June 30,
2021

December 31,
2020

Assets

(Unaudited)


Current assets:



Cash and cash equivalents

$        12,992

$          9,743

Marketable securities

29,634

100,334

Accounts receivable, net

22,444

14,271

Inventories, net

12,977

13,040

Prepaid expenses and other current assets

7,581

3,061

Total current assets

85,628

140,449




Property and equipment, net

52,479

31,624

Right of use asset, net

32,747

34,117

Goodwill and intangible assets, net

23,477

24,083

Other assets

3,975

1,512




Total assets

$      198,306

$      231,785




June 30,
2021

December 31,
2020

Liabilities, redeemable convertible preferred stock, and stockholders' deficit

(Unaudited)


Current liabilities:



   Accounts payable

$        22,642

$        16,128

   Revolving line of credit

2,970

   Current lease liability

2,029

1,627

   Current maturities of long-term debt

7,767

5,466

   Accrued expenses and other current liabilities

15,616

12,315

Total current liabilities

51,024

35,536




Long-term debt

21,096

24,344

Long-term lease liability

33,553

33,982

Preferred stock warrant liability

7,960

5,241

Total liabilities

113,633

99,103




Redeemable convertible preferred stock

287,308

287,323




Stockholders' deficit:



   Common stock, $0.001 par value, 128,467 and 128,467 shares authorized, 6,515 and 5,798 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively

7

6

   Additional paid-in capital

1,849

   Accumulated deficit

(204,089)

(154,322)

   Accumulated other comprehensive loss

(402)

(325)

Total stockholders' deficit

(202,635)

(154,641)

Total liabilities, redeemable convertible preferred stock, and

stockholders' deficit

$      198,306

$      231,785




Benson Hill, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations (Unaudited)

(In Thousands, Except Per Share Information)



Three Months

Ended June 30,

Six Months

Ended June 30,


2021

2020

2021

2020



Revenues

$       39,692

$            31,028

$           71,494

$       62,614

Cost of sales

39,722

26,700

70,955

53,725

Gross profit

(30)

4,328

539

8,889






Operating expenses:





   Research and development

8,818

7,119

15,945

14,766

   Selling, general and administrative expenses

15,761

7,494

29,494

15,463

Total operating expenses

24,579

14,613

45,439

30,229






Loss from operations

(24,609)

(10,285)

(44,900)

(21,340)






Other expense (income):





   Interest expense, net

2,980

2,305

5,254

3,308

   Other (income) expense, net

(170)

159

(388)

180

Total other expense (income), net

2,810

2,464

4,866

3,488

Net loss before income tax

(27,419)

(12,749)

(49,766)

(24,828)

Income tax expense (benefit)

Net loss

$     (27,419)

$         (12,749)

$         (49,766)

$     (24,828)




Net loss per common share:


   Basic and diluted loss per common share

$         (4.34)

$            (2.26)

$          (8.17)

$         (4.44)






Weighted average shares outstanding:





Basic and diluted loss per common share

6,323

5,634

6,092

5,597




Benson Hill, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

(In Thousands)



Three Months

Ended June 30,

Six Months

Ended June 30,


2021

2020

2021

2020



Net loss

$       (27,419)

$       (12,749)

$     (49,766)

$       (24,828)






Foreign currency:





Comprehensive income (loss)

70

(1)

(1)

(243)






Marketable securities:





Comprehensive income (loss)

358

183

271

(109)

Adjustment for net (losses) income realized in net loss

(300)

178

(347)

170






Total other comprehensive income (loss)

128

360

(77)

(182)

Total comprehensive loss

$       (27,291)

$       (12,389)

$       (49,843)

$       (25,010)




Benson Hill, Inc. and Subsidiaries

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit

(Unaudited)

(In Thousands)



Redeemable Convertible
Preferred Stock

Common Stock

Additional Paid-In
Capital

Accumulated
Deficit

Accumulated
Other
Comprehensive
Loss

Total
Stockholders'
Deficit


Shares

Amount

Shares

Amount





Balance at December 31, 2020

102,899

$      287,323

5,798

$                6

$              –

$       (154,322)

$         (325)

$         (154,641)

    Issuance of common stock upon exercise of stock options

136

85

85

    Stock-based compensation expense

647

647

    Other

(15)

(1)

(1)

    Comprehensive loss

(22,347)

(205)

(22,552)

Balance at March 31, 2021

102,899

$       287,308

5,934

$              6

$732

$      (176,670)

$       (530)

$       (176,462)










   Issuance of common stock upon exercise of stock options

581

1

408

409

   Stock-based compensation expense

709

709

   Comprehensive loss

(27,419)

128

(27,291)

Balance at June 30, 2021

102,899

$       287,308

6,515

$              7

$1,849

$       (204,089)

$       (402)

$       (202,635)




Benson Hill, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In Thousands)



Six Months

Ended June 30,


2021

2020

Operating activities


Net loss

$             (49,766)

$             (24,828)

Adjustments to reconcile net loss to net cash used in operating activities:



   Depreciation and amortization

5,430

3,029

   Share-based compensation expense

1,356

504

   Bad debt expense

95

   Remeasurement of preferred stock warrant

2,719

879

   Amortization related to financing activities

805

1,818

   Other

149

139

   Changes in operating assets and liabilities:



      Accounts receivable

(8,173)

(5,793)

      Inventories

63

948

      Prepaid expenses and other current assets

(4,520)

(6,034)

      Accounts payable

3,799

5,061

      Accrued expenses

881

1,654

Net cash used in operating activities

(47,257)

(22,528)




Investing activities



Purchases of marketable securities

(81,604)

Proceeds from maturities of marketable securities

2,050

2,500

Proceeds from sales of marketable securities

150,006

5,648

Payments for acquisitions of property and equipment

(21,128)

(5,142)

Net cash provided by investing activities

49,324

3,006




Financing activities



Principal payments on debt

(1,794)

(1,018)

Proceeds from issuance of debt

24,143

Borrowing under revolving line of credit

14,451

13,683

Repayments under revolving line of credit

(11,481)

(13,928)

Repayments of financing lease obligations

(165)

(50)

Payment of deferred offering costs

(322)

Proceeds from the exercise of stock options and warrants

494

37

Net cash provided by financing activities

1,183

22,867




Effect of exchange rate changes on cash

(1)

(243)




Net increase in cash and cash equivalents

3,249

3,102

Cash and cash equivalents, beginning of period

9,743

2,616

Cash and cash equivalents, end of period

$               12,992

$                 5,718




Supplemental disclosure of cash flow information



Cash paid for taxes

$                        –

$                        –

Cash paid for interest

$                 2,990

$                 1,286




Supplemental disclosure of non-cash investing and financing activities



Issuance of preferred stock warrants

$                        –

$                 4,580

Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities

$                 2,995

$                 1,001

Deferred offering costs included in accounts payable and accrued expenses and other current liabilities

$                 2,139

$                        –

Financing leases

$                        –

$               33,523




Segment Revenues



Three Months

Ended June 30,

Six Months

Ended June 30,

(in thousands)

2021

2020

2021

2020

Revenues





     Ingredients

$            22,724

$             17,819

$           36,919

$            29,554

     Fresh

16,906

12,174

34,470

31,945

     Unallocated and Other

62

1,035

105

1,115

Total Revenues

$            39,692

$             31,028

$           71,494

$            62,614




Segment Profit



Three Months

 Ended June 30,

Six Months

 Ended June 30,

(in thousands)

2021

2020

2021

2020

Adjusted EBITDA





     Ingredients

$              (6,409)

$              (2,557)

$         (13,197)

$           (4,625)

     Fresh

165

895

(172)

2,473

     Unallocated and Other

(9,530)

(6,715)

(17,252)

(15,596)

Total Adjusted EBITDA

$                   (15,774)

$               (8,377)

$          (30,621)

$          (17,748)






Adjustments to reconcile Consolidated Loss from Operations to Adjusted EBITDA

Consolidated loss from operations

$            (24,609)

$             (10,285)

$          (44,900)

$          (21,340)

Depreciation and amortization

2,839

1,632

5,430

3,029

Stock-based compensation

709

217

1,356

504

Non-recurring public company readiness costs

1,955

4,161

South America seed production costs

2,805

2,805

    Other nonrecurring costs, including acquisition costs

527

59

527

59

Adjusted EBITDA

$                   (15,774)

$               (8,377)

$          (30,621)

$          (17,748)

 

Benson Hill Biosystems, Inc. (PRNewsfoto/Benson Hill Biosystems)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/benson-hill-announces-second-quarter-2021-financial-results-301351744.html

SOURCE Benson Hill

Nachrichten zu Star Peak Corp II Registered Shs -A-mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Star Peak Corp II Registered Shs -A-mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!